MedTrace Logo

Evaluation of GeneXpert HIV-1 as The Gold Standard Test for HIV-1 Viral Load Count

NCT05977010 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2023-08-04

No results posted yet for this study

Summary

This is a cohort study on HIV-1 patients treated in outpatient and inpatient wards of Tangerang District Hospital. The participant will be interviewed and retrieved for their demographics, treatment history, CD4 and viral load history. Blood will be drawn for HIV-1 viral load examination using Xpert® HIV-1 Viral Load \[Cepheid\], in-house qRT-PCR, and REALTIME HIV-1 VIRAL LOAD \[Abbott\]

Conditions

Sponsors & Collaborators

  • Ina-Respond

    lead OTHER

Principal Investigators

  • Prof. Dr. dr. Tuti Parwati Merati, Sp.PD.KPTI · Ina-Respond

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2018-01-10
Completion
2018-01-15

Countries

  • Indonesia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05977010 on ClinicalTrials.gov